PRFUF yields 80000.00% · JNJ yields 2.14%● Live data
📍 PRFUF pulled ahead of the other in Year 1
Combined, PRFUF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PRFUF + JNJ for your $10,000?
Prosperous Future Holdings Limited, an investment holding company, manufactures and sells personal care products in the People's Republic of China, Hong Kong, the United States, the United Kingdom, and internationally. It operates through Personal Care Products, Food and Beverage, Financial business, Properties Holding, and Others segments. The company manufactures and sells skin care, body, and hair care products; offers frozen food and beverage products, including meat and poultry; provides frozen warehouse services; and asset management, data analysis, and securities advisory services, as well as deals in securities and futures contracts. In addition, it invests in listed securities and private unlisted funds; offers money lending, finance lease, and factoring services; and provides professional services, such as fund setup and administration, legal and tax consultancy and co-ordination, corporate and accounting, and trust and fiduciary services. Further, the company develops and leases properties; and provides temperature-controlled storage and ancillary services, as well as engages in trading, money lending, and finance lease services. Prosperous Future Holdings Limited was formerly known as Future Development Holdings Limited and changed its name to Prosperous Future Holdings Limited in September 2019. The company was incorporated in 2011 and is headquartered in Central, Hong Kong.
Full PRFUF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.